Lack of Association between Retrospectively Collected Pharmacy Refill Data and Electronic Drug Monitoring of Antiretroviral Adherence

被引:12
作者
Acri, Trisha [1 ]
TenHave, Thomas R. [2 ]
Chapman, Jennifer C. [2 ,3 ]
Bogner, Hillary R. [2 ,4 ]
Gross, Robert [2 ,3 ]
机构
[1] Temple Univ, Dept Family & Community Med, Philadelphia, PA 19140 USA
[2] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[3] Univ Penn, Div Infect Dis, Sch Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Family Practice & Community Med, Philadelphia, PA 19104 USA
关键词
Adherence; HIV-1; Antiretroviral therapy; Pharmacy; Measurement; THERAPY ADHERENCE; PILL COUNTS; VIRAL LOAD; SURVIVAL; FAILURE; RECORDS; WELL;
D O I
10.1007/s10461-008-9502-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Antiretroviral medication refill adherence has not been compared directly to electronic drug monitoring (EDM) in any identifiable published study. We retrospectively studied adults with undetectable HIV titers on highly active antiretroviral therapy. We used Pearson correlation coefficients and receiver operating characteristic curves to relate the two adherence measures, and we used the Wilcoxon rank-sum test to assess the relation between adherence and viral load. In sixty-five subjects, the majority of whom were African American and male with median age of 44 years, pharmacy refill adherence was difficult to collect retrospectively, was not significantly correlated with EDM adherence, and was not significantly related to viral load. Ninety-day supply pharmacy refill adherence correctly classified 95% EDM adherence maximally at 94 days between refills, and the measure was most sensitive for non-adherence at < 90 days. Reassessment of the relation between pharmacy refill data and EDM would be warranted when pharmacy refill data is collected as soon as feasible from sources with complete data capture.
引用
收藏
页码:748 / 754
页数:7
相关论文
共 30 条
[1]   Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population [J].
Bangsberg, DR ;
Hecht, FM ;
Charlebois, ED ;
Zolopa, AR ;
Holodniy, M ;
Sheiner, L ;
Bamberger, JD ;
Chesney, MA ;
Moss, A .
AIDS, 2000, 14 (04) :357-366
[2]   Non-adherence to highly active antiretroviral therapy predicts progression to AIDS [J].
Bangsberg, DR ;
Perry, S ;
Charlebois, ED ;
Clark, RA ;
Roberston, M ;
Zolopa, AR ;
Moss, A .
AIDS, 2001, 15 (09) :1181-1183
[3]  
Bangsberg DR, 2001, J ACQ IMMUN DEF SYND, V26, P435, DOI 10.1097/00126334-200104150-00005
[4]   Practical and conceptual challenges in measuring antiretroviral adherence [J].
Berg, Karina M. ;
Arnsten, Julia H. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 :S79-S87
[5]   The elusive gold standard - Future perspectives for HIV adherence assessment and intervention [J].
Chesney, Margaret A. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 :S149-S155
[6]   Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy [J].
Choo, PW ;
Rand, CS ;
Inui, TS ;
Lee, MLT ;
Cain, E ;
Cordeiro-Breault, M ;
Canning, C ;
Platt, R .
MEDICAL CARE, 1999, 37 (09) :846-857
[7]  
de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014
[8]  
DEYO RA, 1981, J RHEUMATOL, V8, P931
[9]  
Diggle Peter, 2002, Analysis of longitudinal data
[10]   Medication beliefs as mediators of the health literacy-antiretroviral adherence relationship in HIV-infected individuals [J].
Graham, Joseph ;
Bennett, Ian M. ;
Holmes, William C. ;
Gross, Robert .
AIDS AND BEHAVIOR, 2007, 11 (03) :385-392